1.Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.
Keith Y TERADA ; Hyeong Jun AHN ; Bruce KESSEL
Journal of Gynecologic Oncology 2016;27(3):e25-
		                        		
		                        			
		                        			OBJECTIVE: To investigate the role of previous gynecologic surgery, hormone use, and use of non-steroidal anti-inflammatory drugs on the risk of type 1 and type 2 ovarian cancer. METHODS: We utilized data collected for the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. All diagnosed ovarian cancers were divided into three groups: type 1, endometrioid, clear cell, mucinous, low grade serous, and low grade adenocarcinoma/not otherwise specified (NOS); type 2, high grade serous, undifferentiated, carcinosarcoma, and high grade adenocarcinoma/NOS; and other: adenocarcinoma with grade or histology not specified, borderline tumors, granulosa cell tumors. The odds ratios for type 1, type 2, and other ovarian cancers were assessed with regard to historical information for specific risk factors. RESULTS: Ibuprofen use was associated with a decrease in risk for type 1 ovarian cancer. Tubal ligation and oral contraceptive use were associated with a decrease in risk for type 2 ovarian cancer. A history of ectopic pregnancy was associated with a decreased risk for all ovarian cancers by almost 70%. CONCLUSION: These findings support the hypothesis that carcinogenic pathways for type 1 and type 2 ovarian cancer are different and distinct. The marked reduction in all ovarian cancer risk noted with a history of ectopic pregnancy and salpingectomy implies that the fallopian tube plays a key role in carcinogenesis for both type 1 and type 2 ovarian cancer.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Anti-Inflammatory Agents, Non-Steroidal/adverse effects
		                        			;
		                        		
		                        			Contraceptives, Oral, Hormonal/adverse effects
		                        			;
		                        		
		                        			*Early Detection of Cancer
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gynecologic Surgical Procedures/adverse effects
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Ibuprofen/adverse effects
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Ovarian Neoplasms/chemically induced/diagnosis/*etiology/pathology
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Pregnancy, Ectopic/epidemiology
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			
		                        		
		                        	
2.Changes of calcific density in pediatric patients with testicular microlithiasis.
Bumjin LIM ; Sang Hoon SONG ; Geehyun SONG ; Kun Suk KIM
Korean Journal of Urology 2015;56(4):318-323
		                        		
		                        			
		                        			PURPOSE: Testicular microlithiasis (TM) is a relatively rare clinical entity of controversial significance characterized by the existence of hydroxyapatite microliths located in the seminiferous tubules. The aim of this study was to observe the natural course of changes in the calcific density of pediatric TM. MATERIALS AND METHODS: We included a total of 23 TM patients undergoing scrotal ultrasound (US) on at least two occasions from July 1997 to August 2014. We retrospectively analyzed the patient characteristics, clinical manifestations, specific pathological features, and clinical outcomes. We measured the calcified area and compared the calcific density between the initial and final USs. RESULTS: The mean age at diagnosis was 11.3+/-4.6 years, and the follow-up period was 79.1+/-38.8 months (range, 25.4-152.9 months). During the follow-up period, no patients developed testicular cancer. Calcific density on US was increased in the last versus the initial US, but not to a statistically significant degree (3.74%+/-6.0% vs. 3.06%+/-4.38%, respectively, p=0.147). When we defined groups with increased and decreased calcification, we found that diffuse TM was categorized into the increased group to a greater degree than focal TM (10/20 vs. 4/23, respectively, p=0.049). In addition, five of eight cases of cryptorchidism (including two cases of bilateral cryptorchidism) were categorized in the increased calcification group. CONCLUSIONS: Diffuse TM and cryptorchidism tend to increase calcific density. Close observation is therefore recommended for cases of TM combined with cryptorchidism and cases of diffuse TM.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Calcification, Physiologic
		                        			;
		                        		
		                        			*Calculi/complications/epidemiology/pathology/physiopathology
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Cryptorchidism/diagnosis/etiology
		                        			;
		                        		
		                        			Densitometry/methods
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Gonadoblastoma/diagnosis/etiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Scrotum/*ultrasonography
		                        			;
		                        		
		                        			Seminiferous Tubules/*pathology
		                        			;
		                        		
		                        			*Testicular Diseases/complications/epidemiology/pathology/physiopathology
		                        			;
		                        		
		                        			*Testicular Neoplasms/diagnosis/epidemiology/etiology
		                        			
		                        		
		                        	
3.Uric Acid Is a Risk Indicator for Metabolic Syndrome-related Colorectal Adenoma: Results in a Korean Population Receiving Screening Colonoscopy.
Hyo Jin KIM ; Jee Eun KIM ; Ji Hye JUNG ; Eun Ran KIM ; Sung Noh HONG ; Dong Kyung CHANG ; Hee Jung SON ; Poong Lyul RHEE ; Jae J KIM ; Young Ho KIM
The Korean Journal of Gastroenterology 2015;66(4):202-208
		                        		
		                        			
		                        			BACKGROUND/AIMS: An association between serum uric acid and cancer risk has been noted over the past few decades. There is ongoing debate about whether hyperuricemia represents an independent risk factor for colorectal neoplasm. We investigated the association between serum uric acid and prevalence of colorectal adenoma considering numerous confounding factors. METHODS: A cross-sectional study was performed with individuals who underwent a routine health check-up examination, including a screening colonoscopy and blood chemistry. The association between serum uric acid and prevalence of colorectal adenoma was estimated from the results of a logistic regression analysis. RESULTS: Of the 1,066 participants, 402 had colorectal adenoma (37.7%). In univariate models, the prevalence of colorectal adenoma was higher in participants in the fourth quartile uric acid level, compared to those in the first quartile uric acid level (OR, 1.67; 95% CI, 1.17-2.42; p=0.004). However, no significant association was detected between serum uric acid and prevalence of colorectal adenoma in multiple logistic regression analysis. A number of metabolic syndrome components exhibited a strong association with the prevalence of colorectal adenoma in the multivariate model (OR, 3.46 for highest vs. lowest; 95% CI, 1.30-9.20; p=0.021). Moreover, serum uric acid was strongly associated with metabolic syndrome-associated variables, including waist circumference, fasting blood glucose, systolic blood pressure, diastolic blood pressure, triglyceride, and high-density lipoprotein. CONCLUSIONS: Uric acid is not an independent risk factor for colorectal adenoma but is a risk indicator for metabolic syndrome-related colorectal adenoma.
		                        		
		                        		
		                        		
		                        			Adenoma/*diagnosis/epidemiology/etiology
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Blood Glucose/analysis
		                        			;
		                        		
		                        			Blood Pressure
		                        			;
		                        		
		                        			Colonoscopy
		                        			;
		                        		
		                        			Colorectal Neoplasms/*diagnosis/epidemiology/etiology
		                        			;
		                        		
		                        			Cross-Sectional Studies
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Metabolic Syndrome X/*diagnosis
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Odds Ratio
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Triglycerides/blood
		                        			;
		                        		
		                        			Uric Acid/*blood/urine
		                        			;
		                        		
		                        			Waist Circumference
		                        			
		                        		
		                        	
4.Tuberous sclerosis complex and cardiac rhabdomyoma.
Chinese Journal of Pediatrics 2014;52(3):234-237
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Arrhythmias, Cardiac
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Echocardiography
		                        			;
		                        		
		                        			Heart Neoplasms
		                        			;
		                        		
		                        			diagnosis
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Rhabdomyoma
		                        			;
		                        		
		                        			diagnosis
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Tuberous Sclerosis
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			diagnosis
		                        			;
		                        		
		                        			epidemiology
		                        			
		                        		
		                        	
5.Overview of Pediatric Testicular Tumors in Korea.
Korean Journal of Urology 2014;55(12):789-796
		                        		
		                        			
		                        			Prepubertal testicular tumors are rare compared with postpubertal testicular tumors. The incidence of prepubertal testicular tumors peaks at 2 years of age, tapers off after 4 years of age, and then begins to rise again at puberty. Prepubertal and postpubertal testicular tumors show many differences, including the typical tumor histology, molecular biological differences, and the malignant potential of tumors at different ages. Pediatric testicular tumors are classified as benign or malignant on the basis of their clinical behavior and histologically are divided into germ cell and gonadal stromal (nongerm cell) tumors. Many histological and biological studies have further confirmed the distinct nature of prepubertal and postpubertal testicular tumors. These differences have led to various management strategies for prepubertal and postpubertal tumors. Because overall about 75% of prepubertal testicular tumors are benign, a testis-sparing approach is becoming more common in children. Orchiectomy and observation with very selective use of chemotherapy has become the standard approach when a malignant tumor is identified. Retroperitoneal lymph node dissection and radiation therapy play very limited roles.
		                        		
		                        		
		                        		
		                        			Age Distribution
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Republic of Korea/epidemiology
		                        			;
		                        		
		                        			Testicular Neoplasms/*diagnosis/epidemiology/etiology/*therapy
		                        			
		                        		
		                        	
6.Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients.
Jeong Han KIM ; Soon Young KO ; Won Hyeok CHOE ; So Young KWON ; Chang Hong LEE
Clinical and Molecular Hepatology 2013;19(3):273-279
		                        		
		                        			
		                        			BACKGROUND/AIMS: Lamivudine (LAM) plus adefovir (ADV) combination therapy has been accepted as one of the best treatments for LAM-resistant chronic hepatitis B (CHB). The aim of this study was to determine the efficacy of this combination therapy in hepatocellular carcinoma (HCC) patients. METHODS: The medical records of CHB patients who developed LAM resistance and were treated with LAM plus ADV combination therapy for more than 6 months were reviewed. Their virological response (VR; undetectable HBV DNA) and biochemical response (BR; alanine aminotransferase normalization) were evaluated, and the findings of HCC and non-HCC patients were compared. RESULTS: The data from 104 patients (19 with HCC and 85 without HCC) were analyzed. The VR rates did not differ significantly between the HCC and non-HCC groups: 33.3% vs. 55.6% at 12 months (P=0.119), 58.3% vs. 67.2% at 24 months (P=0.742), 50% vs. 69.8% at 36 months (P=0.280), and 66.7% vs. 71.0% at 48 months (P=1.000). The BR rates also did not differ significantly between the groups: 55.6% vs. 84.0% at 12 months (P=0.021), 58.3% vs. 83.8% at 24 months (P=0.057), 70.0% vs. 77.8% at 36 months (P=0.687), and 66.7% vs. 80.6% at 48 months (P=0.591). CONCLUSIONS: The efficacy of LAM plus ADV combination therapy is comparable in HCC and non-HCC patients.
		                        		
		                        		
		                        		
		                        			Adenine/*analogs & derivatives/therapeutic use
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Antiviral Agents/*therapeutic use
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular/*diagnosis/epidemiology/etiology
		                        			;
		                        		
		                        			DNA, Viral/analysis
		                        			;
		                        		
		                        			Drug Administration Schedule
		                        			;
		                        		
		                        			Drug Resistance, Viral
		                        			;
		                        		
		                        			Drug Therapy, Combination
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Hepatitis B virus/genetics
		                        			;
		                        		
		                        			Hepatitis B, Chronic/*drug therapy/virology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Lamivudine/*therapeutic use
		                        			;
		                        		
		                        			Liver Cirrhosis/diagnosis/epidemiology/etiology
		                        			;
		                        		
		                        			Liver Neoplasms/*diagnosis/epidemiology/etiology
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Organophosphonates/*therapeutic use
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
7.Does periprostatic block increase the transrectal ultrasound (TRUS) biopsy sepsis rate in men with elevated PSA?
Valerie H L GAN ; Tricia L C KUO ; Lui Shiong LEE ; Hong Hong HUANG ; Hong Gee SIM
Annals of the Academy of Medicine, Singapore 2013;42(4):168-172
INTRODUCTIONPeriprostatic nerve block (PPNB) is a common local anaesthetic technique in transrectal ultrasound-guided (TRUS) prostate biopsy, but concerns remain over the increased theoretical risks of urinary tract infection (UTI) and sepsis from the additional transrectal needle punctures. This study reviewed our biopsy data to assess this risk.
MATERIALS AND METHODSRetrospective data collected from 177 men who underwent TRUS biopsy between July 2007 and December 2009 in a single institution were analysed. PPNB was administered using 1% xylocaine at the prostatic base and apex and repeated on the contralateral side under ultrasound guidance. Complications, including UTI sepsis, bleeding per rectum and acute retention of urine (ARU) were noted. Every patient was tracked for the first 2 weeks for complications until his clinic review. Demographic profi le, biopsy parameters and histological fi ndings were reviewed. Univariate and multivariate analysis of possible risk factors for development of sepsis after TRUS biopsy were performed. Statistical analysis was performed using SPSS 17.0.
RESULTSNinety (51%) men received PPNB and 87 (49%) did not. The groups were matched in age (PPNB: mean 62.7 ± 5.8 years; without PPNB: mean 64.4 ± 5.7 years) and prebiopsy prostate specific antigen (PSA) levels (PPNB: mean 8.2 ± 3.9 ng/mL; without PPNB: mean 8.3 ± 3.7 ng/mL). The PPNB group had a larger prostate volume, with more cores taken (P <0.05). On univariate and multivariate analysis controlling for age, PSA, prostate volume, number of cores taken and histological prostatitis, PPNB was not a significant risk factor for sepsis. Sepsis rates were 5.6% in the PPNB group and 5.7% in the other group (P = 0.956). Overall prostate cancer detection rate was 33.3%.
CONCLUSIONThe risk of sepsis was not increased in patients who received PPNB, even though this group had larger gland volumes and more biopsy cores taken.
Aged ; Biopsy, Needle ; adverse effects ; methods ; Endosonography ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Nerve Block ; adverse effects ; methods ; Prostate-Specific Antigen ; blood ; Prostatic Neoplasms ; blood ; diagnosis ; Retrospective Studies ; Risk Factors ; Sepsis ; blood ; epidemiology ; etiology ; Singapore ; epidemiology
8.Helicobacter pylori Seropositivity Is Positively Associated with Colorectal Neoplasms.
Kwan Woo NAM ; Myong Ki BAEG ; Jung Hyun KWON ; Soung Hoon CHO ; Soo Jin NA ; Myung Gyu CHOI
The Korean Journal of Gastroenterology 2013;61(5):259-264
		                        		
		                        			
		                        			BACKGROUND/AIMS: Helicobacter pylori is a well known precursor to gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma. This study was to determine whether H. pylori was associated with colorectal neoplasms in Korean subjects undergoing routine checkup. METHODS: A total of 10,082 subjects underwent routine checkups from January 2004 to April 2005. A H. pylori IgG test and stool occult blood test were included in the routine checkup program. Colonoscopy was performed if the stool occult blood test was positive or under subject request. Patients who underwent colonoscopy and had histologically confirmed cases of colorectal neoplasms were designanted as the subject group and those without as the control group. RESULTS: Of the 10,082 subjects, 597 had full colonoscopy. The results identified 9 colorectal carcinomas and 118 adenomas. H. pylori seropositivity was identified in 6 (66%) subjects with colorectal carcinoma, 81 (68.6%) with colorectal adenoma and 248 (52.8%) controls. Subjects having colorectal neoplasms had a significantly higher H. pylori seropositivity rate compared with the controls (OR 1.94, 95% CI 1.28-2.95). This remained significant after adjusting for age, sex, body mass index, HbA1c and total cholesterol (OR 1.90, 95% CI 1.23-2.93). Patients with distal neoplasms also had a significantly higher H. pylori seroposivity rate (OR 1.88, 95% CI 1.17-3.01) which persisted after multivariate adjustment (OR 1.79, 95% CI 1.10-2.94). CONCLUSIONS: Subjects with colorectal neoplasms present an increased H. pylori seroprevalence compared with controls.
		                        		
		                        		
		                        		
		                        			Adenoma/*diagnosis/etiology
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Age Factors
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Body Mass Index
		                        			;
		                        		
		                        			Cholesterol/blood
		                        			;
		                        		
		                        			Colonoscopy
		                        			;
		                        		
		                        			Colorectal Neoplasms/*diagnosis/epidemiology/etiology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Helicobacter Infections/complications/*diagnosis
		                        			;
		                        		
		                        			Helicobacter pylori/*immunology
		                        			;
		                        		
		                        			Hemoglobin A, Glycosylated/analysis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoglobulin G/analysis
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Occult Blood
		                        			;
		                        		
		                        			Odds Ratio
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Sex Factors
		                        			
		                        		
		                        	
9.Clinical Characteristics of Idiopathic Pulmonary Fibrosis Patients with Diabetes Mellitus: the National Survey in Korea from 2003 to 2007.
Yu Jin KIM ; Jeong Woong PARK ; Sun Young KYUNG ; Sang Pyo LEE ; Man Pyo CHUNG ; Young Hwan KIM ; Jae Ho LEE ; Yong Chul KIM ; Jong Seon RYU ; Hong Lyeol LEE ; Choon Sik PARK ; Soo Tak UH ; Young Chul LEE ; Kwan Hyung KIM ; Young Joon CHUN ; Young Bum PARK ; Dong Soon KIM ; Yongjin JEGAL ; Jin Hwa LEE ; Moo Suk PARK ; Sung Hwan JEONG
Journal of Korean Medical Science 2012;27(7):756-760
		                        		
		                        			
		                        			Evidence suggests that diabetes mellitus (DM) is associated with idiopathic pulmonary fibrosis (IPF). According to the new IPF guidelines, high-resolution computed tomography (HRCT) is an essential means of diagnosing IPF. We investigated the relationship between IPF and DM in patients treated between 2003 and 2007. Newly diagnosed IPF patients in large university teaching hospitals in Korea were enrolled from January 2003 to December 2007. We retrospectively analyzed 1,685 patients using the interstitial lung disease (ILD) registry. In total, 299 IPF patients (17.8%) also had DM. The mean age of our subjects was 68.0 +/- 9.4 yr. HRCT showed significantly more reticular and honeycomb patterns in IPF patients with DM than in IPF patients without DM (P = 0.014, P = 0.028, respectively). Furthermore, significantly higher incidences of hypertension, cardiovascular diseases, and other malignancies (except lung cancer) were found in IPF patients with DM than in IPF patients without DM. In conclusion, IPF patients with DM are more likely to have the usual interstitial pneumonia (UIP) pattern, including reticular and honeycomb patterns, on HRCT than are those without DM.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Cardiovascular Diseases/epidemiology/etiology
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/*complications
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypertension/epidemiology/etiology
		                        			;
		                        		
		                        			Idiopathic Pulmonary Fibrosis/complications/*diagnosis/radiography
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Neoplasms/epidemiology/etiology
		                        			;
		                        		
		                        			Registries
		                        			;
		                        		
		                        			Republic of Korea/epidemiology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			
		                        		
		                        	
10.Type and cause of liver disease in Korea: single-center experience, 2005-2010.
Sang Soo LEE ; Young Sang BYOUN ; Sook Hyang JEONG ; Yeo Myung KIM ; Ho GIL ; Bo Young MIN ; Mun Hyuk SEONG ; Eun Sun JANG ; Jin Wook KIM
Clinical and Molecular Hepatology 2012;18(3):309-315
		                        		
		                        			
		                        			BACKGROUND/AIMS: The aim of this study was to describe the types and causes of liver disease in patients from a single community hospital in Korea between April 2005 and May 2010. METHODS: A cohort of patients who visited the liver clinic of the hospital during the aforementioned time period were consecutively enrolled (n=6,307). Consistent diagnostic criteria for each liver disease were set by a single, experienced hepatologist, and the diagnosis of all of the enrolled patients was confirmed by retrospective review of their medical records. RESULTS: Among the 6,307 patients, 528 (8.4%) were classified as acute hepatitis, 3,957 (62.7%) as chronic hepatitis, 767 (12.2%) as liver cirrhosis, 509 (8.1%) as primary liver cancer, and 546 (8.7%) as a benign liver mass or other diseases. The etiologies in the acute hepatitis group in decreasing order of prevalence were hepatitis A (44.3%), toxic hepatitis (32.4%), other hepatitis viruses (13.8%), and cryptogenic hepatitis (9.1%). In the chronic hepatitis group, 51.2% of cases were attributed to viral hepatitis, 33.3% to nonalcoholic fatty liver disease, and 13.0% to alcoholic liver disease (ALD). Of the cirrhoses, 73.4% were attributable to viral causes and 18.1% to alcohol. Of the hepatocellular carcinoma cases, 86.6% were attributed to viral hepatitis and 11.6% to ALD. Among the benign tumors, hemangioma comprised 52.2% and cystic liver disease comprised 33.7%. CONCLUSIONS: Knowledge of the current status of the type and cause of liver disease in Korea may be valuable as a basis for evaluating changing trends in liver disease in that country.
		                        		
		                        		
		                        		
		                        			Acute Disease
		                        			;
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Alcohol Drinking/adverse effects
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular/epidemiology/etiology/pathology
		                        			;
		                        		
		                        			Chronic Disease
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Fatty Liver/epidemiology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hepatitis/epidemiology
		                        			;
		                        		
		                        			Hepatitis, Viral, Human/complications/epidemiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver Cirrhosis/epidemiology/etiology
		                        			;
		                        		
		                        			Liver Diseases/*diagnosis/epidemiology
		                        			;
		                        		
		                        			Liver Diseases, Alcoholic/complications/epidemiology
		                        			;
		                        		
		                        			Liver Neoplasms/epidemiology/etiology/pathology
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Republic of Korea/epidemiology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail